Elliot Marseille - UC Berkeley Healthcare Economist on the Financial Viability of Psychedelic Therapy
Will MDMA and psychedelic therapy be affordable? There are lots of questions about the economic and financial future of psychedelic therapies. How much will they cost? Will insurance cover them? And...
6 Aug 202352min
Founder of the AI Responsibility Lab, Ramsay Brown on AI Safety, AI Coworkers & ChatGPT doing DMT
🤖 ChatGPT & Dall-E today - misinformation, bias & worker displacement tomorrow. In a world where artificial intelligence is becoming increasingly advanced, it's more important than ever to ensure tha...
3 Mar 20231h 24min
Zach Haigney, Author of The Trip Report - Future Trends in Psychedelic Medicine
Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape. In this conversation, Zach and Brom discuss emerging trends, ...
9 Jul 202258min
Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics
Sam Banister is a medicinal chemist and co-founder of Psylo. Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic ...
30 Jun 20221h 1min
Music For Psychedelic Therapy - Mendel Kaelen, Founder and CEO of Wavepaths
Mendel Kaelen is the CEO of Wavepaths. Prior to founding Wavepaths, Mendel Kaelen worked as a PhD and postdoctoral neuroscientist at Imperial College London since 2012, where his research was the one...
8 Mai 20221h
Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment
Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment. In this episode Tom speaks on the severity of the opioid epidemic a...
27 Mar 202258min
Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator
Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditi...
10 Feb 202241min
27: Juan Pablo Cappello - CEO of Nue Life
Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approach to patient health, leveraging ketamine and the i...
9 Jan 202257min
